Response to Letter to the Editor: "p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer".
Loading...
Embargo End Date
ICR Authors
Authors
Turnbull, C
Loveday, C
Izatt, L
Ellard, S
Loveday, C
Izatt, L
Ellard, S
Document Type
Journal Article
Date
2018-09-01
Date Accepted
2018-07-12
Abstract
Citation
The Journal of clinical endocrinology and metabolism, 2018, 103 (9), pp. 3518 - 3519
Rights
Source Title
Publisher
ENDOCRINE SOC
ISSN
0021-972X
eISSN
1945-7197